Jordi Antón López
Jefe de Grupo Senior
Research group
Jordi Antón López is a Paediatric rheumatologist, Head of Section of the Paediatric Rheumatology Unit at the SJD Barcelona Children's Hospital. Doctor in Medicine from the University of Barcelona, of which he is an associate professor. Since 2013 he has been the director of the master's degree in Paediatric Rheumatology at the same university.
He has been the president of the Spanish Society of Paediatric Rheumatology (SERPE) (2011-2019), and is currently chair of the Education and Training Committee and member of the Council of PRES (Paediatric Rheumatology European Society) and active member of PRINTO (Paediatric Rheumatology International Trials Association). Director of the Study group of diseases due to immune dysfunction in Paediatrics (GEMDIP) recognized as a Pre-Consolidated Group by the Catalan Agency for Management of University and Research Grants (AGAUR) (2017 SGR 1547) and framed within the line on Infectious Diseases and Systemic Immune Response of the Sant Joan de Déu Research Institute (IRSJD).
He has participated as a researcher in 22 R+D+i projects financed in competitive calls of Administrations or public and private entities, and in 33 R & D contracts, agreements or projects that are not competitive with public or private administrations or entities. He has directed doctoral thesis in Kawasaki disease and autoinflammatory diseases.
With 103 publications, its H index is 29. The sum of Impact Factor is 710,355, with 3.273 total citations. In the last 5 years the number of publications is 63, of them 42 in the first quartile and 27 in the first decile, with a sum of the impact factor of the last 5 years of 461,607.
Professional network profiles
Related websites
Last Publications
- Correia Marques M, Rubin D, Shuldiner EG, Datta M, Schmitz E, Gutierrez Cruz G, Patt A, Bennett E, Grom A, Foell D, Gattorno M, Bohnsack J, Yeung RSM, Prahalad S, Mellins E, Anton-Lopez J, Len CA, Oliveira S, Woo P, Ozen S, Deng Z and Ombrello MJ Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis. ARTHRITIS & RHEUMATOLOGY . 76(10): 1566-1572.
- Marshall DA, Gerber B, Currie GR, Anton-Lopez J, De Somer L, Dey M, Egert T, Egert Y, Henan L, Klotsche J, Martinez-Mifsut L, Minden K, Normand C, Porte D, Saurenmann RK, Swart JF, Uziel Y, Wilson J, Wouters C, Ziv A and Benseler SM Uncovering the hidden socioeconomic impact of juvenile idiopathic arthritis and paving the way for other rare childhood diseases: an international, cross-disciplinary, patient-centered approach (PAVE Consortium). PEDIATRIC RHEUMATOLOGY . 22(1): 74-74.
- Carriqui S, Mosquera-Angarita JM, Quesada-Masachs E, López M, Clemente D, Boteanu A, Udaondo C, de Inocencio J, Nieto JC, Riancho L, Núñez E, Sánchez-Manubens J, Lirola MJ, Roldán R, Camacho M, Martínez M, Medrano M, Alcañiz P, Anton-Lopez J and Iglesias-Jimenez E Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry PEDIATRIC RHEUMATOLOGY . 22(1): 66-66.
Projects
- Project name:
- Estudio piloto de la creación de un commmand center clínico
- Leader
- Jordi Antón López
- Funding entities:
- Swedish Orphan Biovitrum, S.L.
- Code
- PCP00404
- Starting - finishing date:
- 2023 - 2024
- Project name:
- SGR 2022-2024_Grup d'Estudi de Malalties per Disfunció Immune en Pediatria (GEMDIP)
- Leader
- Jordi Antón López
- Funding entities:
- Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
- Code
- 2021 SGR 01250
- Starting - finishing date:
- 2022 - 2025
- Project name:
- Estudio piloto para la creación de un “command center” clínico en un servicio de reumatología pediátrica
- Leader
- Jordi Antón López
- Funding entities:
- Sociedad Española de Reumatología Pediátrica (SERPE)
- Code
- PCP00363
- Starting - finishing date:
- 2022 - 2024
News
-
Mutation in DOCK11 gene explains rare disorder in immune system regulation
Researchers from the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children's Hospital participate in an international study, published in the prestigious scientific journal New England Journal of Medicine, which describes for the first time a new disease of the immune system caused by a mutation of the DOCK11 gene.
-
The european ImmunAID project starts its clinical phase
The ImmunAID project aims to develop new diagnostic signatures for systemic auto-inflammatory diseases (SAID). Ultimately, the aim is to offer better care for these rare disease patients. Systemic auto-inflammatory diseases (SAID) are a complex and poorly understood group of rare diseases.